## CRWV: CoreWeave, Inc. - XLK: Technology

### Executive Summary

No thesis match: PEG unavailable fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($69.71)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Roth Capital | $110 | $0 | 0% |
| 2025-12-05 | Freedom Capital | $100 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Roth Capital | init | Buy |
| 2025-12-05 | Freedom Capital | init | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Magnetar Financial L: 21.2% (-14.4%)
- FMR, LLC: 6.9% (+7.1%)
- Nvidia Corp         : 6.3% (0.0%)
- Jane Street Group, L: 3.2% (+143.8%)
- Vanguard Group Inc: 1.9% (+109.7%)

### Key Risks

1. High beta (3.36) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Elevated short interest (14.2%): bears positioning against stock.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Momentum building: MRS_20 improving +18.3% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

Revenue growth strong at 135% YoY. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $42.3B |
| Beta | 1.00 |
| 52W Range | $33.52 - $187.00 |
| Short Interest | 14.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | N/A |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_20 strengthening from -10.8% to 7.4% (+18.3% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 92nd percentile. MRS_5 at 13.3% confirms short-term momentum alignment. AM_20 at 7.9% shows strong absolute momentum above own 20MA. Outperforming sector by 7.2pp, stock-specific strength. Below SMA200 (1.00x), long-term trend not supportive. MACD histogram positive (1.38), confirming momentum. RSI neutral at 51. Elevated volume (1.4x 20MA), institutional activity likely. OFD pattern: -DUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 7.41% (CS: 92) | Strong |
| RSI_14 | 51.1 | Neutral |
| MACD Histogram | 1.38 | Bullish |
| vs SMA20 | 1.079x | Above |
| vs SMA50 | 0.859x | Below |
| vs SMA200 | 1.000x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $84.83
- **Stop Loss:** $69.71 (17.8% risk)
- **Target:** $99.95 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 79
- **Position Value:** $6,701.57
- **Portfolio %:** 6.70%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-03-24 (Est: $-0.68)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.49 | $-0.22 | +55.1% |
| 2025Q2 | $-0.49 | $-0.60 | -21.7% |
| 2025Q1 | $-0.22 | $-1.40 | -538.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*